Eupraxia Pharmaceuticals Statistics
Total Valuation
EPRX has a market cap or net worth of $195.63 million. The enterprise value is $205.93 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
EPRX has 35.96 million shares outstanding. The number of shares has increased by 21.81% in one year.
Current Share Class | 35.96M |
Shares Outstanding | 35.96M |
Shares Change (YoY) | +21.81% |
Shares Change (QoQ) | +0.63% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 24.88M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 9.33 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.72, with a Debt / Equity ratio of 0.00.
Current Ratio | 8.72 |
Quick Ratio | 7.60 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -81.82 |
Financial Efficiency
Return on equity (ROE) is -169.25% and return on invested capital (ROIC) is -93.38%.
Return on Equity (ROE) | -169.25% |
Return on Assets (ROA) | -75.00% |
Return on Invested Capital (ROIC) | -93.38% |
Return on Capital Employed (ROCE) | -138.93% |
Revenue Per Employee | n/a |
Profits Per Employee | -$890,344 |
Employee Count | 33 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, EPRX has paid $10,179 in taxes.
Income Tax | 10,179 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +100.37% in the last 52 weeks. The beta is 1.54, so EPRX's price volatility has been higher than the market average.
Beta (5Y) | 1.54 |
52-Week Price Change | +100.37% |
50-Day Moving Average | 4.98 |
200-Day Moving Average | 3.80 |
Relative Strength Index (RSI) | 55.84 |
Average Volume (20 Days) | 11,103 |
Short Selling Information
The latest short interest is 166,522, so 0.46% of the outstanding shares have been sold short.
Short Interest | 166,522 |
Short Previous Month | 170,839 |
Short % of Shares Out | 0.46% |
Short % of Float | 0.67% |
Short Ratio (days to cover) | 13.23 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -29.14M |
Pretax Income | -23.08M |
Net Income | -29.38M |
EBITDA | -28.98M |
EBIT | -29.14M |
Earnings Per Share (EPS) | -$0.86 |
Full Income Statement Balance Sheet
The company has $19.77 million in cash and $35,065 in debt, giving a net cash position of $19.73 million or $0.55 per share.
Cash & Cash Equivalents | 19.77M |
Total Debt | 35,065 |
Net Cash | 19.73M |
Net Cash Per Share | $0.55 |
Equity (Book Value) | 20.98M |
Book Value Per Share | -0.25 |
Working Capital | 20.21M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$30.46 million and capital expenditures -$421,859, giving a free cash flow of -$30.89 million.
Operating Cash Flow | -30.46M |
Capital Expenditures | -421,859 |
Free Cash Flow | -30.89M |
FCF Per Share | -$0.86 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
EPRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.81% |
Shareholder Yield | -21.81% |
Earnings Yield | -15.02% |
FCF Yield | -15.79% |
Analyst Forecast
The average price target for EPRX is $11.50, which is 111.01% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.50 |
Price Target Difference | 111.01% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -23.05% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |